We are live on ! Find out more
ASMB icon

Assembly Biosciences

106 hedge funds and large institutions have $700M invested in Assembly Biosciences in 2020 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 49 increasing their positions, 23 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 49 | Existing positions reduced: 23

100% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 8

56% more capital invested

Capital invested by funds: $449M → $700M (+$251M)

8% more funds holding

Funds holding: 98106 (+8)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.09% less ownership

Funds ownership: 7.73%7.64% (-0.09%)

Holders
106
Holders Change
+8
Holders Change %
+8.16%
% of All Funds
2.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
16
Increased
49
Reduced
23
Closed
8
Calls
$542K
Puts
Net Calls
+$542K
Net Calls Change
+$1.31M

ASMB Hedge Fund Activity: Q2 2020 in Review

106 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q2 2020, worth a combined $700M — up 56% from $449M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new ASMB positions and 8 closed out — a net gain of 8 holders — while 49 added to existing stakes and 23 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $10.9M. The largest seller was Victory Capital Management, cutting an estimated $32.9M.

  • 106 institutional investors held Assembly Biosciences (ASMB) as of Q2 2020, up from 98 in Q1 2020.
  • Funds reported $700M of Assembly Biosciences stock for Q2 2020, up 56% quarter-over-quarter.
  • 16 funds opened new Assembly Biosciences positions in Q2 2020 and 8 closed out, a net change of +8 holders.
  • The largest Assembly Biosciences buyer in Q2 2020 was EcoR1 Capital, an estimated $10.9M added.
  • The largest Assembly Biosciences seller in Q2 2020 was Victory Capital Management, an estimated $32.9M sold.

Based on aggregated 13F filings for Q2 2020.